Topical Bevacizumab for Corneal Neovascularization and Neovascular Glaucoma

被引：0
|
作者：
Waisbourd, M. [1 ]
Zayit-Soudry, S. [1 ]
Loewenstein, A. [1 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Dept Ophthalmol, Tel Aviv, Israel
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
cornea: clinical science; anterior segment; neovascularization;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5709
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Topical Bevacizumab in the Treatment of Corneal Neovascularization
    Dastjerdi, Mohammad H.
    Al-Arfaj, Khalid M.
    Nallasamy, Nambi
    Hamrah, Pedram
    Jurkunas, Ula V.
    Pineda, Roberto, II
    Pavan-Langston, Deborah
    Dana, Reza
    ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (04) : 381 - 389
  • [2] Topical bevacizumab therapy for corneal neovascularization
    DeStafeno, John J.
    Kim, Terry
    ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (06) : 834 - 836
  • [3] Topical Bevacizumab for Neovascular Glaucoma: A Pilot Study
    Waisbourd, Michael
    Shemesh, Gabi
    Kurtz, Shimon
    Rachmiel, Rony
    Moisseiev, Elad
    Zayit-Soudri, Shiri
    Loewenstein, Anat
    Barequet, Irina
    PHARMACOLOGY, 2014, 93 (3-4) : 108 - 112
  • [4] Effects of Intravitreal Bevacizumab on Anterior Segment Neovascularization in Neovascular Glaucoma
    Ishibashi, S.
    Tawara, A.
    Sohma, R.
    Kubota, T.
    Toh, N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [5] High-Dose Topical Bevacizumab for Corneal Neovascularization
    Waisbourd, Michael
    Levinger, Eliya
    Varssano, David
    Moisseiev, Elad
    Zayit-Soudri, Shin I.
    Barak, Adiel
    Loewenstein, Anat
    Barequet, Irina
    PHARMACOLOGY, 2013, 92 (5-6) : 310 - 314
  • [6] The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization
    Asena, Leyla
    Akova, Yonca A.
    Cetinkaya, Altug
    Kucukerdonmez, Cem
    ACTA OPHTHALMOLOGICA, 2013, 91 (03) : E246 - E248
  • [7] Topical bevacizumab for corneal neovascularization after penetrating keratoplasty
    Saxena, Sandeep
    Kishore, Poonam
    Pandey, Sukant
    Khattri, Mohit
    Kumar, Dipak
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2009, 19 (05) : 870 - 872
  • [8] Clinical Outcomes of Topical Bevacizumab for the Treatment of Corneal Neovascularization
    Jamaludin, Mohd Ihsan
    Halim, Wan Haslina Wan Abdul
    Cheng, Teck Chee
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [9] Bevacizumab (Avastin (R)) for the management of anterior chamber neovascularization and neovascular glaucoma
    Brouzas, Dimitrios
    Charakidas, Antonios
    Moschos, Marilita
    Koutsandrea, Chryssanthi
    Apostolopoulos, Michael
    Baltatzis, Stefanos
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 685 - 688
  • [10] Comparison of the effect of topical bevacizumab and sorafenib in experimental corneal neovascularization
    Yildirim, Hakan
    Aydemir, Orhan
    Balbaba, Mehmet
    Ozercan, Ibrahim Hanifi
    Ilhan, Nevin
    CUTANEOUS AND OCULAR TOXICOLOGY, 2020, 39 (03) : 223 - 228
12345